Join Us for Adherence 2020 Virtual
Health professionals and advocates for people living with HIV will meet virtually November 2-3, 2020, for the Adherence 2020 Virtual conference. The conference's faculty will address antiretroviral therapy and biomedical prevention adherence within the context of optimized care and prevention continua and during the COVID-19 pandemic.

The conference’s program will feature plenaries, panel discussions, and oral/poster abstract presentations across five tracks: Adherence, Combination HIV Prevention, Continuum of Care, Community Engagement, and Implementation Science. Pre-recorded content will supplement live-streamed plenaries and panel discussions.

Dr. Shannon Hader, Deputy Executive Director for Programs at the Joint United Nations Programme on HIV/AIDS (UNAIDS), will deliver the conference’s keynote address regarding a universal HIV test-and-connect approach to attain the 90-90-90 targets within the context of COVID-19 HIV service disruptions. Her keynote address will commence at 9:15 am EST, November 2, 2020.

Adherence 2020 Virtual is made possible through grant support and sponsorships from Gilead Sciences, Janssen Therapeutics, Merck & Co., and ViiV Healthcare.
COVID-19 in the Americas Conference Launched in October 2020

IAPAC is joining with the AHF Global Public Health Institute and the Institute for Advanced Study of The Americas at the University of Miami to sponsor a six-month virtual conference aimed at exploring the multifaceted ways in which the lives of people across North, Central, and South America have been affected by the COVID-19 pandemic.

COVID-19 in The Americas began this week with a series of online panels including two framing panel discussions that featured IAPAC President/CEO Dr. José M. Zuniga and AIDS Healthcare Foundation (AHF) President Michael Weinstein, as well as Dr. Julio Frenk, President of the University of Miami, and the Executive Directors of the AHF Global Public Health Institute (Dr. Jorge Saavedra) and the Institute for Advanced Study of The Americas (Dr. Felicia Knaul).

Registration is available free-of-charge. Registrants will receive email updates as new panel discussions and plenary sessions are scheduled to take place from October 2020 through March 2021. All sessions will be archived on IAPAC's website (www.IAPAC.org).
IAPAC Promotes Self-Advocacy against Implicit Bias
IAPAC conducted a virtual workshop entitled, Affirming Life: Self-Advocacy against Implicit Bias in Clinical Settings Delivering HIV Services, which took place during the National Minority AIDS Council's 2020 US Conference on HIV/AIDS.

The workshop, which is available on IAPAC's YouTube channel, included a discussion moderated by Dr. June Gipson (My Brother's Keeper, Ridgeland, MS, USA) with testimonials from two people living with HIV: Daniel Driffin (THRIVE SS, Atlanta, GA, USA) and Antoinette Jones (Sister Love, Atlanta, GA, USA), Each spoke about their own experiences in dealing with implicit biases.

The workshop also included a plenary presentation by Dr. Carey Roth Bayer (Morehouse School of Medicine, Atlanta, GA, USA), who defined "implicit bias" and described its impact on people's ability and willingness to access and utilize HIV services.
IAPAC and Lancet HIV Partner on Urban HIV Response Commission

IAPAC and the Lancet HIV are embarking on a partnership over the coming year through an IAPAC-Lancet HIV Commission on the Future of Urban HIV Responses (IAPAC-Lancet HIV Commission) whose focus will be defining a pathway towards achieving Sustainable Development Goals (SDGs) 3 and 11 - ending the epidemics of HIV, TB, and viral hepatitis, and promoting inclusive, safe, resilient, and sustainable cities and municipalities, respectively.

A regionally diverse, multidisciplinary group of Commissioners and Advisors have been tasked with: 1) reflecting on the calculus of political will, community engagement, and data-driven/equity-based HIV responses to close gaps across the HIV prevention and treatment continua and end HIV-related stigma; 2) documenting experiences and best practices in urban HIV responses; 3) reinforcing the need to address HIV-associated comorbidities and syndemic conditions; 4) examining structural barriers to achieving SDGs 3 and 11 in urban settings (e.g., social and economic inequality, health and other disparities, and intersectional stigma; and 5) addressing the threat posed by the COVID-19 pandemic and future pandemics.

The IAPAC-Lancet HIV Commission's work is made possible through grant support from ViiV Healthcare and the Fast-Track Cities Institute.
IAPAC Endorses Virology Education's Online Meeting Highlights

IAPAC is partnering with Virology Education, a provider of innovative scientific and educational programs, by endorsing and promoting a new online resource to our membership. Online Meeting Highlights (OMH) is an educational resource designed for health professionals to stay up to date with developments in the clinical management of HIV. The OMH resource is comprised of three modules containing 15- to 20-minute video presentations, relevant literature, post-presentation tests, and links to related international conferences.
European HIV-Hepatitis Testing Week 2020 will take place November 20-27, 2020. Testing and linkage to HIV and viral hepatitis prevention and treatment services is critical to averting new infections and curbing mortality, particularly because Undetectable = Untransmittable (U=U) for HIV and due to the availability of direct-acting antivirals that can cure HCV infection. IAPAC is an official partner supporting a week of HIV and viral hepatitis testing awareness activities across the European Fast-Track Cities network.
IAPAC Welcomes New Staff

IAPAC welcomes Justin Hill as our new Regional Director for Fast-Track Cities in North America. Prior to joining IAPAC, he was a Senior Program Officer at FHI 360 for over seven years, most recently working in Mozambique. He was also previously a Research and Fulbright Fellow at the Ministry of Health of Barbados. Mr. Hill will take over from Dashiell Sears, who now serves as IAPAC's Director of Advocacy and Public Policy.

JIAPAC Editor Emeritus Pick
Development and Validation of HIV/AIDS Stigma/Discrimination Scale in Southeast Iran: The General Population Viewpoint

Researchers in Iran evaluate effectiveness of a new scale for measuring HIV-related stigma in an article for the latest edition of the Journal of the International Association of Providers of AIDS Care (JIAPAC)